Q&A: Adult-Onset LCH Is Rare, Varies Widely, & Can Be Misdiagnosed
Langerhans cell histiocytosis is more common in children than adults, resulting in sparse data and uncertainty in diagnosing and treating adult-onset disease.
Read MoreNov 29, 2023
Langerhans cell histiocytosis is more common in children than adults, resulting in sparse data and uncertainty in diagnosing and treating adult-onset disease.
Read MoreNov 28, 2023
An evidence-based guideline to help healthcare professionals give sound advice regarding mental health to people with cancer is sorely needed.
Read MoreNov 27, 2023
Many barriers exist in the recruitment for diabetic macular edema clinical trials of patients of minority racial and ethnic backgrounds.
Read MoreNov 27, 2023
Key risk factors for progression independent of relapse activity in relapsing-remitting MS include age and longer disease duration.
Read MoreNov 27, 2023
Participating in a group behavioral telehealth program may improve the ability of patients with MS to achieve clinically meaningful weight loss.
Read MoreNov 27, 2023
More targeted, higher efficacious medications can drastically reduce the risk for accruing disability in newly diagnosed patients with MS.
Read MoreNov 24, 2023
Patients treated for biliary tract cancer who lived in states with expanded Medicare showed improved treatment outcomes.
Read MoreNov 22, 2023
2023 NACLC is taking place in Chicago’s famous “Magnificent Mile” district, so be sure to set aside a little time for exploring!
Read MoreNov 22, 2023
Check out the fascinating array of topics to be covered during 2023 NACLC satellite CME symposia!
Read MoreNov 22, 2023
The IASLC 2023 North America Conference on Lung Cancer (NACLC) runs December 1-3, 2023, at the...
Read MoreNov 22, 2023
Developmental delays are a widely recognized feature of Bardet-Biedl syndrome (BBS); however, there is little research on the challenges faced by people with BBS.
Read MoreNov 21, 2023
While there is still no cure for food allergies, oral immunotherapy is a popular treatment to reduce children’s risk for reaction upon accidental exposure.
Read MoreNov 20, 2023
The use of physical therapy for patients with pneumonia appears to be highly variable in US hospitals and is impacted by patient age, race, and comorbidities.
Read MoreNov 17, 2023
For patients with primary progressive MS, age is a particularly important factor that predicts disease activity.
Read MoreNov 17, 2023
Although statistically significant, the effect of orbital decompression on Graves’-associated upper eyelid retraction does not appear have clinical implications.
Read MoreNov 17, 2023
Researchers observed an increased risk of sick leave in patients with MS several years before clinical onset of the disease.
Read MoreNov 16, 2023
Results of a registry study confirmed that early intensive treatment enhances long-term clinical outcomes by minimizing the accumulation of neurological damage.
Read MoreNov 16, 2023
The onset of MS-related progressive brain tissue loss (PBTL) precedes clinical disease onset by 5 to 6 years.
Read MoreNov 16, 2023
The benefits of interleukin inhibitors vary by agent and include increased drug survival and earlier attainment of Psoriasis Area Severity Index scores.
Read MoreNov 16, 2023
Aflibercept 8 mg shows efficacy for patients with diabetic macular edema regardless of sex, age, and race/ethnicity.
Read More